VI
ELV icon

Vestcor Inc’s Elevance Health ELV Stock Holding History

Vestcor Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Sell
38,715
-2,655
-6% -$985K 0.37% 59
2026
Q1 		$12.1M Sell
41,370
-3,690
-8% -$1.21M 0.33% 73
2025
Q4 		$15.8M Buy
45,060
+700
+2% +$237K 0.45% 47
2025
Q3 		$14.3M Buy
44,360
+10,186
+30% +$3.17M 0.43% 50
2025
Q2 		$13.3M Buy
34,174
+20,400
+148% +$8.21M 0.4% 61
2025
Q1 		$5.99M Sell
13,774
-1,143
-8% -$459K 0.2% 110
2024
Q4 		$5.5M Sell
14,917
-230
-2% -$96.2K 0.18% 122
2024
Q3 		$7.88M Buy
15,147
+13
+0.1% +$6.95K 0.25% 95
2024
Q2 		$8.2M Hold
15,134
– – 0.28% 87
2024
Q1 		$7.85M Sell
15,134
-1,320
-8% -$656K 0.27% 86
2023
Q4 		$7.76M Sell
16,454
-54
-0.3% -$25K 0.26% 86
2023
Q3 		$7.19M Sell
16,508
-3,562
-18% -$1.62M 0.26% 91
2023
Q2 		$8.92M Sell
20,070
-714
-3% -$329K 0.33% 70
2023
Q1 		$9.56M Buy
20,784
+6,696
+48% +$3.19M 0.35% 65
2022
Q4 		$7.23M Buy
14,088
+14
+0.1% +$7.11K 0.27% 89
2022
Q3 		$6.39M Buy
14,074
+64
+0.5% +$30.6K 0.24% 97
2022
Q2 		$6.76M Buy
14,010
+7,120
+103% +$3.52M 0.25% 93
2022
Q1 		$3.38M Buy
6,890
+1,951
+40% +$892K 0.12% 200
2021
Q4 		$2.29M Sell
4,939
-817
-14% -$344K 0.08% 242
2021
Q3 		$2.15M Sell
5,756
-500
-8% -$190K 0.08% 263
2021
Q2 		$2.39M Sell
6,256
-7,410
-54% -$2.83M 0.08% 266
2021
Q1 		$4.91M Buy
13,666
+6,781
+98% +$2.18M 0.18% 151
2020
Q4 		$2.21M Sell
6,885
-1,059
-13% -$325K 0.09% 266
2020
Q3 		$2.13M Sell
7,944
-164
-2% -$44.1K 0.1% 233
2020
Q2 		$2.13M Buy
8,108
+1,535
+23% +$410K 0.11% 210
2020
Q1 		$1.49M Buy
6,573
+905
+16% +$247K 0.08% 252
2019
Q4 		$1.71M Buy
+5,668
New +$1.56M 0.08% 272

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vestcor Inc's ELV Position: Q2 2026 in Review

Vestcor Inc reduced its Elevance Health (ELV) stake by 6.4% in Q2 2026, selling an estimated $985K and leaving 38,715 shares worth $15M. The position accounts for 0.37% of the portfolio, ranked #59.

Vestcor Inc first reported a position in ELV in Q4 2019 and has held it in 27 quarters since. The position peaked at $15.8M in Q4 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vestcor Inc held 38,715 shares of Elevance Health worth $15M as of Q2 2026.
  • Vestcor Inc sold 2,655 Elevance Health shares in Q2 2026, an estimated $985K.
  • Elevance Health made up 0.37% of Vestcor Inc's portfolio in Q2 2026, its #59 holding.
  • Vestcor Inc first reported a position in Elevance Health in Q4 2019 and has held it in 27 quarters since.
  • Vestcor Inc's Elevance Health position peaked at $15.8M in Q4 2025.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.